We would like to emphasize that this is the first study involving selected matrilysin and stromelysin family members as novel diagnostic biomarkers in a rare histological type of ovarian cancer, i.e., endometrioid ovarian cancer. Here, MMP7 is linked to ovarian endometrioid adenocarcinoma.